Prot #KD025-213: Phase 2, Randomized, Multicenter Study to Evaluate the Efficacy and Safety of KD025 in Subjects with Chronic Graft Versus Host Disease (cGVHD) After At Least 2 Prior Lines of Systemic Therapy (The ROCKstar Study)

Project: Research project

Project Details

Effective start/end date5/16/195/16/22


  • Medpace Clinical Research LLC (Prot #KD025-213 // Prot #KD025-213)
  • Kadmon Corporation, LLC (Prot #KD025-213 // Prot #KD025-213)